Name: UMIN ID:
| Unique ID issued by UMIN | UMIN000014307 |
|---|---|
| Receipt number | R000016659 |
| Scientific Title | Phase IIb double blinded parallel group dose response study for DVC1-0101 to treat severe intermittent claudication |
| Date of disclosure of the study information | 2014/09/01 |
| Last modified on | 2024/12/26 09:53:56 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/06/18 19:23:38 | ||
| 2 | Update | 2024/12/26 09:43:10 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Organization Organization Organization Category of Funding Organization Organization Organization Address Address Tel Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 Institutions |
|
| 3 | Update | 2024/12/26 09:47:44 | URL releasing protocol |
|
| 4 | Update | 2024/12/26 09:50:27 | Recruitment status Date of IRB Last follow-up date Other related information |
|
| 5 | Update | 2024/12/26 09:52:38 | Last follow-up date |
|
| 6 | Update | 2024/12/26 09:53:56 | URL releasing protocol Number of participants that the trial has enrolled |